PRGO
PerrigoDNYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-11
Current thesis
Composite grade D from latest DB weights. Momentum 19.3 / Value 66.5
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.3.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
19
Value
66
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-06-11
Fundamentals
As of 2026-06-11 • Vendor: Data Vendor v1
Scores
As of 2026-06-11 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-06-11
Investment thesis
As of 2026-06-11
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $16.00
Why
Momentum19 · Δ7d +3.9
Value66 · Δ7d -0.3
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
19
52% active weight
Current posture
7d trendImproving
Δ7d
+3.9
Δ21d
-3.7
Value
66
48% active weight
Current posture
7d trendFlat
Δ7d
-0.3
Δ21d
-0.1
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade D. Momentum 19.3 / Value 66.5
Fundamentals (TTM)As of 2026-06-11
Fundamentals (TTM)
As of 2026-06-11
Market Cap
$1.51B
Beta
0.39
Shares Out
137.62M
P/E (TTM) · Derived
-1.1
P/S (TTM)
0.46
P/FCF (TTM)
17.35
Rev YoY
-4.1%
EPS YoY
+171.4%
Gross Margin
+35.5%
Op Margin
+6.5%
Net Debt
$3.06B
Current Ratio
2.51
As of 2026-06-11 • Updated nightlySource: Internal modelMethodology